Industry Overview

Kidney stones treatment market was valued at $4.20 billion in 2025 and is projected to reach $ 7.53 billion by 2035, growing at a CAGR of 6.0% during the forecast period (2026-2035). The market is growing due to the rising prevalence of kidney stone disorders, driven by changing dietary patterns, sedentary lifestyles, and increasing metabolic conditions such as obesity and diabetes. This trend has led to higher demand for both minimally invasive and conventional treatment options, including ESWL, ureteroscopy, and percutaneous nephrolithotomy, as well as medication-based therapies for stone management and prevention. Technological advancements in lithotripsy systems and endoscopic devices are further supporting market expansion by improving procedural efficiency, safety, and patient outcomes. Additionally, increasing awareness among patients and healthcare providers about early diagnosis and treatment options is contributing to greater adoption of advanced urology interventions.

Market Dynamics

Rising Adoption of Minimally Invasive Procedures

The market is witnessing increased adoption of minimally invasive procedures, such as ureteroscopy and percutaneous nephrolithotomy, due to their lower complication rates and shorter recovery periods compared with open surgery. Hospitals and specialized urology centers are investing in advanced endoscopic equipment and laser lithotripsy systems to meet growing patient demand. Regulatory approvals for novel devices and favorable reimbursement policies in key regions are facilitating broader access to these technologies. The shift toward minimally invasive approaches is also encouraging manufacturers to enhance device precision and efficiency. As a result, the preference for less invasive interventions is driving procedural volume growth and stimulating innovation within the market.

Expansion of Outpatient and Ambulatory Treatment Settings

The market is benefiting from the increasing availability of outpatient and ambulatory surgical centers for kidney stone management, which reduces hospitalization costs and enhances patient convenience. Facilities equipped with portable lithotripsy and endoscopy systems are enabling rapid treatment of both simple and complex stones in non-hospital settings. This trend is supported by advancements in compact and high-efficiency devices that maintain clinical effectiveness outside traditional hospital environments. Patient preference for same-day procedures and shorter recovery times is further accelerating the adoption of these care settings. Consequently, the expansion of outpatient services is contributing to higher treatment volumes and broadening the overall market reach.

Market Segmentation

• Based on the stone type, the market is segmented into calcium stone, uric acid stone, struvite stone, and cystine stone.
• Based on the treatment type, the market is segmented into extracorporeal shock wave lithotripsy, ureteroscopy, percutaneous nephrolithotomy, medication/drug therapy, and open surgery.

Calcium Stone Segment Leading Growth

The calcium stone sub-segment is the largest within the kidney stones market, driven by its high prevalence across global populations due to dietary imbalances and metabolic disorders. Rising cases of hypercalciuria and related conditions are increasing clinical demand for both preventive and interventional treatments. Healthcare providers are prioritizing early diagnosis through imaging and biochemical testing, supporting timely intervention and reducing recurrence rates. Technological improvements in ESWL and ureteroscopy specifically targeting calcium stones are enhancing treatment efficiency and patient outcomes.

Extracorporeal Shock Wave Lithotripsy (ESWL) Sub-Segment Growth

The ESWL treatment sub-segment is expanding rapidly due to its non-invasive nature, which offers reduced patient recovery time and lower procedural risk compared with surgical alternatives. Adoption is increasing in both hospital and outpatient settings as portable and high-precision lithotripters become more widely available. Advancements in imaging-guided shock wave delivery have improved fragmentation efficiency and treatment success rates, reinforcing clinician preference. Insurance coverage and favorable reimbursement policies in several regions are further supporting broader adoption. This sub-segment’s convenience, safety, and technological enhancements are key contributors to its leading growth within the treatment category.

Regional Outlook

The global Kidney Stones Treatment market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds the Leading Position in the Global Kidney Stones Treatment Market

North America holds the leading position in the global kidney stones treatment market, driven by high disease prevalence, advanced healthcare infrastructure, and strong adoption of minimally invasive technologies such as ESWL and ureteroscopy. Well-established reimbursement frameworks and extensive diagnostic capabilities support early detection and timely intervention. Major industry participants, including Boston Scientific Corporation, Medtronic plc, and Olympus Corporation, maintain significant operations and device launches in the region. Continuous technological innovation, coupled with increasing patient awareness, sustains steady procedural growth. The region’s robust healthcare ecosystem and strong clinical adoption make it the primary contributor to market revenue.

Asia-Pacific Is the Fastest Growing Market for Kidney Stones Treatment

Asia-Pacific is the fastest growing market for kidney stone treatment, fueled by rising incidence of urolithiasis, urbanization-driven lifestyle changes, and expanding healthcare access across emerging economies. Increasing investments in modern lithotripsy systems and endoscopic devices are enhancing treatment availability in both hospital and outpatient settings. Countries such as China, India, and Japan are witnessing strong demand for minimally invasive procedures, supported by government healthcare initiatives and private sector expansion. Key players, including Karl Storz SE & Co. KG and Lumenis Ltd., are actively targeting regional adoption through local partnerships and distribution networks.

Market Players Outlook

The major companies operating in the global Kidney Stones Treatment market include Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical LLC, Karl Storz SE & Co. KG, Olympus Corporation, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In March 2026, Boston Scientific received FDA 510(k) clearance for the Asurys™ Fluid Management System, which optimizes irrigation and manages intrarenal pressure in real-time during ureteroscopy and other urologic procedures. When used with the LithoVue™ Elite ureteroscope, it improves visualization and safety. The system will soon have a limited US release and expand Boston Scientific’s StoneSmart™ Solutions for kidney stone care, enhancing procedural efficiency and supporting advanced ureteroscopic treatments.
• In January 2026, SonoMotion received FDA 510(k) clearance for the Break Wave™ lithotripsy system, a non-invasive ultrasound device that fragments kidney stones without anesthesia or stents. Usable in various clinical settings, it expands treatment options and promotes less invasive care. The clearance was supported by the pivotal SOUND trial, which will be presented at major urology conferences later in 2026.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global kidney stones treatment market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.